Interpace Biosciences, Inc. (IDXG)

Trade IDXG now with
2/1/2021 9:59:06 AM Interpace Biosciences Reaches License Agreement With Rutgers University And Mass General Hospital
3/11/2020 10:57:42 PM Interpace Diagnostics Updates Contract With BCBS Of Massachusetts
1/6/2020 7:01:43 AM Interpace Enters Collaborative Study To Assess Use BarreGEN After Ablation Of Dysplastic Barrett’s Esophagus
7/22/2019 6:59:07 AM Interpace Diagnostics Enters New Agreement With SelectHealth
7/15/2019 4:32:10 PM Interpace Diagnostics Acquires Cancer Genetics’ Biopharma Services Business
1/25/2019 6:02:19 AM Interpace Diagnostics Announces Pricing Of Public Offering Of 9.33 Mln Shares At $0.75/Shr
1/24/2019 4:36:18 PM Interpace Diagnostics Announces Proposed Public Offering Of Common Stock
1/22/2019 6:56:19 AM Interpace Diagnostics Finalizes Validation Of Third Specimen Type For Molecular Thyroid Tests ThyGeNEX And ThyraMIR
1/14/2019 6:57:18 AM Interpace Diagnostics Enters Deal With University Of Maryland Medical System
12/17/2018 6:52:35 AM Interpace Reports Notice Of Allowance From USPTO Covering BarreGEN
11/13/2018 4:27:48 PM Interpace Diagnostics Q3 Loss/share $0.11 Vs. Loss $0.15 Year Ago